Subscribe to Newsletter

Small Molecules

Business & Regulation Standards & Regulation

This Week’s Biopharma News: EU Launches Initiative to Attract Scientists from US

| Stephanie Vine | 4 min read

Our latest news roundup reports on Novartis’ new acquisition, an NIH grant for an Alzheimer’s disease vaccine, and more
Discovery & Development Dosage Forms

Going From Benchtop Chemist to CEO: Part 2

| Stephanie Vine | 5 min read

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.
Business & Regulation Standards & Regulation

Trump's New Push on Drug Pricing

| Rob Coker | 2 min read

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.
Manufacture Advanced Medicine

Coming Soon: the Power List

| Rob Coker | 2 min read

The 2025 Power List will be available soon!
Discovery & Development Drug Discovery

Combatting the Side Effects of Treatments for Parkinson’s

| 4 min read

Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.
Discovery & Development Drug Discovery

Antibiotics: Going With the Flow

| Rob Coker | 2 min read

How fluid flow through the body can affect the ways in which antibiotics work.
Business & Regulation Standards & Regulation

The Future of the NIH

| Hernan Bazan | 2 min read

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.
Business & Regulation Business Practice

Calling Out Misleading Information

| Rob Coker | 2 min read

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.
Manufacture Technology and Equipment

The Myths and Reality of Hot Melt Extrusion

| Hibreniguss Terefe, Shahab Kashani Rahimi | 6 min read

How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.
Business & Regulation Standards & Regulation

GSK’s Flovent Strategy Under Federal Scrutiny?

| Rob Coker | 2 min read

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Latest White Papers

Ploughshare® Mixer for batch operation in pharmaceutical production: well-established all-rounder

| Contributed by Lodige

Beyond Heat – Practical Requirements of a Microwave Synthesizer

| Contributed by Biotage

Efficiencies in manufacturing

| Contributed by ACG

MDRS used to confirm the pharmaceutical equivalence of Oral Solid Dose (OSD) products

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

February Issue of The Medicine Maker